Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
|
|
Hepion Pharmaceuticals, Inc. (CTRV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2022 |
3
| Reddi Anand (Director) has filed a Form 3 on Hepion Pharmaceuticals, Inc. |
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/02/2019 |
3
| Garlikov Donald E (10% Owner) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 12/15/2016 |
3
| HOWSON TAMAR D (Director) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 09/21/2016 |
3
| ADAMS THOMAS PHD (Director) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 08/17/2016 |
3
| CERRONE GABRIEL (10% Owner) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 06/16/2016 |
3
| Foster Robert T (Chief Scientific Officer) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 04/20/2016 |
3
| Cavan John T (CFO) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 10/07/2013 |
3
| SYNERGY PHARMACEUTICALS, INC. (10% Owner) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 10/07/2013 |
3
| Denoyer Bernard (CFO and Secretary) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 10/07/2013 |
3
| BRANCACCIO JOHN P (Director) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
| 10/07/2013 |
3
| JACOB GARY S (CEO and President) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
|
|